Lorazepam as an adjunct to antiemetic therapy in patients receiving cytotoxic chemotherapy.
D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006801:Humans; D008140:Lorazepam / Q000627:therapeutic use*; D009325:Nausea / Q000517:prevention & control*; D014839:Vomiting / Q000517:prevention & control
D000932:Antiemetics; D000970:Antineoplastic Agents; D008140:Lorazepam